- Abstract Number: 560
Dactylitis Occurrence in Early Spondyloarthritis: Five Years Data from a French National Prospective Cohort
- Abstract Number: 1277
Damage and Comorbidities in a Cohort of Patients with Idiopathic Inflammatory Myopathy
- Abstract Number: 769
Damage in Takayasu‘s Arteritis Is Associated with Age at Symptom-onset, Disease-duration and Corticosteroid Dose but Not Relapse in Routine Follow-up
- Abstract Number: 1356
DAS28-CRP Cut-offs for High Disease Activity Assessment Is Lower Than DAS28-ESR in Rheumatoid Arthritis
- Abstract Number: 2435
Data Driven Prediction Lymphoma Model and 10-year Overall Survival Rates of a Large Harmonized Cohort of Patients with Primary Sjögren’s Syndrome Associated Lymphomas
- Abstract Number: 2857
Decision Tree Analysis to Identify Inflammatory Arthritis Patient Subgroups with Different Levels of Treatment Persistence with First-Line Subcutaneous TNF-alpha Inhibitors
- Abstract Number: 2731
Decomposition Analysis of Spending and Price Trends for Biologic Anti-Rheumatic Drugs in Medicare and Medicaid
- Abstract Number: 644
Decreased HVEM Expression in Lupus Patients and Impact of HVEM Knockout Mouse Model of Lupus Suggest a Role for BTLA Signaling in Disease Pathogenesis
- Abstract Number: 476
Decreased Muscle Mass, a Novel Predicting Indicator for One-year Radiographic Progression in Rheumatoid Arthritis: A Real-world Cohort Study
- Abstract Number: 1561
Decreased Nocturnal Blood Pressure Dipping in Patients with Systemic Lupus Erythematosus: Association with Markers of Inflammation
- Abstract Number: 1159
Deep Learning Social Media Analysis Demonstrated Gender-Specific Disparity in Side Effects from Rheumatoid Medications
- Abstract Number: 2561
Deep Remission During Induction Therapy for Lupus Nephritis Prevents Damage Accrual and Associates with the Baseline Proportions of Peripheral Treg, CD8+ T Cells, and NKT-like Cells
- Abstract Number: 116
Defective EZH2 Expression Attenuates Treg Differentiation in Rheumatoid Arthritis
- Abstract Number: 1789
Defibrotide Inhibits Antiphospholipid Antibody-Mediated NET Release and Endothelial Cell Activation
- Abstract Number: 1358
Defining Minimal Clinically Important Changes for the Patient Activity Scale-II
- Abstract Number: 1592
Defining the SLE-Associated Pulmonary Arterial Hypertension Phenotype
- Abstract Number: 299
Definition of New Ultrasound Enthesophytes Score: Application in a Consecutive Series of IBD Patients
- Abstract Number: 2854
Delay Between the Onset of Psoriasis and Arthritis in PsA Patients from the PsART International Cohort
- Abstract Number: 1187
Delayed Gadolinium-enhanced MR Imaging of Cartilage – A Pilot Study to Measure the Effect of Adalimumab Plus MTX versus Placebo Plus MTX on Cartilage in Early RA Patients (CAR-ERA-Study)
- Abstract Number: 1812
Delineating Early Response Trajectories to Biologics in Polyarticular Course Juvenile Idiopathic Arthritis
- Abstract Number: 717
Dental Health in Systemic Sclerosis Patients Risk Factors and Comorbidities
- Abstract Number: 1741
Depression and Anxiety Symptoms in Childhood-Onset Systemic Lupus Erythematosus
- Abstract Number: 2822
Depression and Subsequent Risk for Incident Seronegative Rheumatoid Arthritis Among Women
- Abstract Number: 913
Depression as a Moderator of Analgesic Effectiveness in Knee Osteoarthritis
- Abstract Number: 2172
Depression of Vitamin D Levels After Adult Primary Posterior Spinal Fusion: Are We Adding Insult to Injury?
- Abstract Number: 178
Depression: A Common Comorbidity in Rheumatic Diseases. a Case-Control Study
- Abstract Number: 339
Depressive Symptoms Influence Success of Allopurinol in Reducing Serum Urate
- Abstract Number: 2350
Derivation and Validation of a Biomarker-Based Cardiovascular Risk Prediction Score in Rheumatoid Arthritis
- Abstract Number: 2888
Deriving Accurate Prednisone Dosing from Electronic Health Records: Analysis of a Natural Language Processing Tool for Complex Prescription Instructions
- Abstract Number: 67
Dermal Lymphatic Dysfunction Is Associated with Disease Activity in the MRL/lpr Lupus Model
- Abstract Number: 1826
Describing Intra-Individual Cognitive Function Course over Time in Lupus Patients: Persistent and Fluctuating Cognitive Impairment, Affected Cognitive Domains, and Severity
- Abstract Number: 259
Describing Treatment Patterns and Healthcare Costs in Newly Diagnosed Psoriatic Arthritis Patients by Physician Specialty
- Abstract Number: 2497
Description and Prevalence of Spondyloarthritis in Unselected Patients with Psoriasis, Acute Anterior Uveitis, and Inflammatory Bowel Disease Presenting with Undiagnosed Back Pain
- Abstract Number: 1793
Descriptive Analysis of Biopsy-proven Antiphospholipid Antibody-associated Nephropathy Patients Included in the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
- Abstract Number: 2173
Descriptive Analysis of Patient-Reported Home Exercise and Physical Activity and Their Associations with Patient Baseline Characteristics Following Total Knee Replacement
- Abstract Number: 2552
Design and Development of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change
- Abstract Number: 1680
Design of a Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of 2 Different Dose Regimens of IFX-1, a C5a Inhibitor, as an Add-On Therapy for Granulomatosis with Polyangiitis or Microscopic Polyangiitis
- Abstract Number: 255
Designing and Testing Treat to Target as a New Care Model in JIA Across a Network of Pediatric Rheumatology Centers
- Abstract Number: 2430
Detection and Clinical Significance of Circulating M3 Muscarinic Acetylcholine Receptor Reactive Th17 Cells in Patients with Primary Sjögren’s Syndrome
- Abstract Number: 2310
Determinants of Cognitive Function in Rheumatoid Arthritis (RA) Patients
- Abstract Number: 237
Determination of Muscle Pressure in Patients with Fibromyalgia by Two Examiners; The Examiners Get Similar Results
- Abstract Number: 1965
Determining a Polygenic Risk Score in Pediatric Systemic Lupus Erythematosus
- Abstract Number: 747
Detrimental Factors Affecting the First-year Clinical Response in Korean Patients with Polymyalgia Rheumatica
- Abstract Number: 267
Develop Risk Prediction Model and Drug Withdrawl Road Map Through Pattern Extraction and Data Mining: Create a Master Algorithm from the Smart System of Disease Management (SSDM)
- Abstract Number: 2201
Developing a Comprehensive Patient-Specific Disease Progression Prediction Model for Knee Osteoarthritis Using Machine/Deep Learning Methods
- Abstract Number: 916
Development and Initial Validation of the MS Score for Diagnosis of Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 915
Development and Initial Validation of the Systemic JADAS, a New Composite Disease Activity Score for Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 2666
Development and Outcome of Aortic Complications During Tocilizumab (TCZ) Treatment of GCA and Histopathologic Evidence of Residual Inflammation
- Abstract Number: 2750
Development and Preliminary Validation of a Novel Lung Ultrasound Interpretation Criteria for the Detection of Interstitial Lung Disease in Patients with Systemic Sclerosis
- Abstract Number: 168
Development and Usability Testing of Take Charge: An Email Series to Increase Knowledge of Self-Management Skills in People with Lupus
- Abstract Number: 1176
Development and Validation of a Preliminary MRI Sacroiliac Joint Composite Structural Damage Score in a 5-year Longitudinal Study of Patients with Axial Spondyloarthritis
- Abstract Number: 2516
Development of a Biomarker Panel for Prediction of Disease Flares in Systemic Lupus Erythematosus
- Abstract Number: 1919
Development of a Multi-Modality Imaging Approach to Evaluate Lupus Nephritis
- Abstract Number: 341
Development of a Multivariable Improvement Measure for Gout
- Abstract Number: 990
Development of a Novel Anti TNF-Steroid Antibody Drug Conjugate That Shows Promising Efficacy at Doses That Avoid Steroid Side Effects in a Mouse Model of Rheumatoid Arthritis
- Abstract Number: 562
Development of a Set of ASAS Quality Standards for Adults with Axial Spondyloarthritis
- Abstract Number: 1101
Development of an Algorithm to Identify Sjögren’s Syndrome Patients in the French National Healthcare Claims Database
- Abstract Number: 601
Development of an Optimized Online Self-Referral Tool for Early Recognition of Patients with Axial Spondyloarthritis – Data from the OptiRef Study
- Abstract Number: 1580
Development of Comorbidity in Danish Nationwide Cohort of Newly Diagnosed Patients with Systemic Lupus Erythematosus
- Abstract Number: 798
Development of Large Vessel Vasculitis Including Aortitis in a Patient with Deficiency of the IL-1 Receptor Antagonist (DIRA) Points to Converging Roles of IL-1 and TNF in Vascular Pathogenesis Recapitulating Findings from a Murine Model
- Abstract Number: 1698
Development of Machine Learning Models (Artificial Neural Networks) for Prediction of Vision Threatening Behçet’s Disease
- Abstract Number: 145
Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase II Results
- Abstract Number: 1109
Development of Smart-phone Spondyloarthritis Management System and Real-world Study of Chinese Patients with Ankylosing Spondylitis
- Abstract Number: 1758
Development of Ultrasound Detectable Arthritis Among ACPA Positive Subjects with Musculoskeletal Symptoms: The Risk RA Prospective Study
- Abstract Number: 2217
DEXA Does Not Accurately Reflect FRAX Score in Patients with Autoimmune Disease on Corticosteroids
- Abstract Number: 718
Diagnosing Pulmonary Hypertension Using the Proposed 6th World Symposium on Pulmonary Hypertensions New Definitions
- Abstract Number: 832
Diagnosis of Fibromyalgia: Comparison of AAPT and ACR Criteria
- Abstract Number: 2127
Diagnosis of Inflammatory Rheumatic Diseases: Preliminary Approach by Urine Metabolomics
- Abstract Number: 723
Diagnosis of Systemic Sclerosis: How and When
- Abstract Number: 633
Diagnostic Delay in Spondyloarthritis
- Abstract Number: 491
Diagnostic Performance of Anti-cyclic Citrullinated Peptide (CCP) 2 and CCP3.1 Assays in Early Rheumatoid Arthritis
- Abstract Number: 559
Diagnostic Utility of Individual Inflammatory Back Pain Parameters in Patients with Axial Spondyloarthritis
- Abstract Number: 193
Diet as a Risk Factor for Rheumatoid Arthritis
- Abstract Number: 829
Dietary Intake Does Not Explain Microbiome Alterations or Symptom Severity in Fibromyalgia
- Abstract Number: 2927
Dietary Patterns and Symptomatic Progression of Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- Abstract Number: 89
Difference of Induced CD4+ and Natural Regulatory T Cells in Targeting Inflamed Synovial Tissues in Autoimmune Arthritis
- Abstract Number: 2482
Differences and Similarities According to Gender in Patients with Psoriatic Arthritis Initiating Biological Therapy
- Abstract Number: 783
Differences in Chromatin Architecture in Treatment Naïve Pediatric Lupus Patients
- Abstract Number: 2489
Differences in Clinical Characteristics, Quality of Life, Disability, and Work Productivity in Psoriatic Arthritis Patients by Gender: Findings from a Cross-sectional Survey in the US and Europe
- Abstract Number: 1156
Differences in Clinical Outcomes According to the Healthcare Regime in Colombian Patients with Rheumatoid Arthritis
- Abstract Number: 425
Differences in Correlation Between Objective Disease Measurements and Patient’s/physician’s Global Assessment in the Large Non-interventional Study SUSTAIN
- Abstract Number: 2229
Differences in Fracture Risk Assessment (FRAX) and Osteoporosis Treatment Cutoffs with and Without Bone Mineral Density Are Greater in Anti-Cyclic Citrullinated Peptide Positive Rheumatoid Arthritis
- Abstract Number: 2090
Differences in Stepping and Standing Based on Self-reported Exercise Identity in Persons Following Total Knee Replacement
- Abstract Number: 2818
Differences in the Phenotypic Landscape and Antigen Specificity of CD4+ T Cells Are Present in CCP+ Subjects Before the Onset of Rheumatoid Arthritis
- Abstract Number: 1268
Different Colchicine Preparations for Familial Mediterranean Fever: Are They the Same?
- Abstract Number: 1839
Different Patterns and Specific Outcomes of Large-Vessel Involvements in Giant Cell Arteritis
- Abstract Number: 2598
Different Treatment Backgrounds Do Not Influence Aminaphtone Efficacy in Primary and Secondary Raynaud’s Phenomenon
- Abstract Number: 2504
Differential Expression of Human Endogenous Retroviruses in Psoriatic Disease
- Abstract Number: 2738
Differential Methylation of Peripheral Blood Adaptive Immune Cells in Individuals at High Risk for RA and with Early RA Compared with Controls Identifies Pathways Important in Transition to Arthritis
- Abstract Number: 697
Differing Opinions on Clinical Research Between Healthcare Providers and Lupus Patients
- Abstract Number: 726
Digital Blood Perfusion Differences Between Black Africans and Caucasians with Systemic Sclerosis
- Abstract Number: 2746
Dimethyl Fumarate Ameliorates the GATA6 Deficiency-Induced Pulmonary Hypertension by Normalizing Oxidative and ER Stress
- Abstract Number: 659
Diminished Memory B-cells in Systemic Lupus Erythematosus Patients with Low Disease Activity
- Abstract Number: 1129
Direct Medical and Societal Cost of Opioid Use in Symptomatic Knee Osteoarthritis Patients in the United States
- Abstract Number: 1598
Disability Among Subtypes of SLE
- Abstract Number: 1923
Disability and Health-Related Quality of Life Outcomes in Patients with Systemic or Polyarticular Juvenile Idiopathic Arthritis Treated with Tocilizumab in Randomized Controlled Phase 3 Trials
- Abstract Number: 1438
Discontinuation of Concomitant Methotrexate in Japanese Patients with Rheumatoid Arthritis Treated with Tocilizumab: An Interventional Study
- Abstract Number: 521
Discontinuation of Disease Modifying Drugs Due to Inefficacy in Patients with Incident Rheumatoid Arthritis
- Abstract Number: 2370
Discontinuation of Disease Modifying Drugs in Patients with Incident Rheumatoid Arthritis
- Abstract Number: 1385
Discontinuation of Oral Glucocorticoid After Initiation of Biological DMARDs Due to a Higher Dose of Methotrexate; A Retrospective Observational Study Based on Data from a Japanese Multicenter Registry Study
- Abstract Number: 965
Discovery of DWP212525, a Potent JAK3 and BTK Dual Target Inhibitor for the Treatment of Autoimmune Diseases
- Abstract Number: 36
Discovery, Verification and Validation of Rheumatoid Arthritis Activity Monitoring Biomarkers
- Abstract Number: 1925
Discriminant and Predictive Ability of the Parent Version of the Juvenile Arthritis Disease Activity Score in Two Large Multination Cohorts of Patients with Juvenile Idiopathic Arthritis
- Abstract Number: 1612
Disease Activity and Cognitive Function in Systemic Lupus Erythematosus
- Abstract Number: 1588
Disease Activity and Dysregulated Iron Metabolism: A Potentially Overlooked Mechanism for Anaemia in Patients with Systemic Lupus Erythematosus?
- Abstract Number: 1726
Disease Activity and Health Care Utilization Among Young Adults with Childhood-onset Lupus Transitioning to Adult Care: Follow-Up Data from the Pediatric Lupus Outcomes Study
- Abstract Number: 440
Disease Activity and Quality of Life in Behçet’s Syndrome: The Role of Patient Reported Outcome
- Abstract Number: 1725
Disease Activity in Childhood-Onset Systemic Lupus Erythematosus: Initial Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry
- Abstract Number: 2515
Disease Activity Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Psoriatic Artrhitis
- Abstract Number: 502
Disease Activity Measures at Baseline and 3 Months as Predictors of Rapid Radiographic Progression in Methotrexate Naïve Patients with Early Rheumatoid Arthritis
- Abstract Number: 839
Disease Activity, Cytokine Profiles, and the Risk of Incident Diabetes in Rheumatoid Arthritis
- Abstract Number: 1699
Disease Course of Behçet’s Syndrome Patients Not Fulfilling International Study Group Criteria at Presentation
- Abstract Number: 2292
Disease Flares of Rheumatoid Arthritis During Pregnancy: What Is the Impact of Stopping bDMARDs at the Beginning of Pregnancy?
- Abstract Number: 1724
Disease Manifestations and Impact on Quality of Life in Subjects with Pre-Pubertal Onset Systemic Lupus Erythematosus
- Abstract Number: 972
Disease Severity Is Linked to an Increase in Autoantibody Diversity in IgG4-related Disease
- Abstract Number: 880
Diseased Lupus Nephritis Kidneys Serve as a Primary Site of Systemic Autoimmune Development
- Abstract Number: 658
Disentangling Connective Tissue Diseases: Overlaps and Disparities in Clinical Diagnosis, Classification Criteria and Autoantibodies – Results from the Lupus Extended Autoimmune Phenotype Study
- Abstract Number: 1980
Disorganization of Chondrocyte Columns in the Growth Plate During Experimental Osteoarthritis in Mice
- Abstract Number: 1057
Dissecting the Cellular Mechanism of Prostacyclin Analog Iloprost in Reversing Vascular Dysfunction in Scleroderma
- Abstract Number: 1038
Distinct Cell-bound Complement Activation Signatures Are Observed in Patients with Systemic Lupus Erythematosus
- Abstract Number: 719
Distinct Characteristics of the Gut Microbiome of Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth
- Abstract Number: 2426
Distinct Clinical Characteristics of Anti-Ro/SSA Negative Primary Sjögren’s Syndrome: Data from a Cohort for Sjögren’s Syndrome in Korea
- Abstract Number: 385
Distinctive Clinical Features and Biomarkers of Connective Tissue Disease Associated Interstitial Lung Disease
- Abstract Number: 1711
Distinctive Imaging Features Between IgG4-Related Ophthalmic Disease and Graves’ Orbitopathy: A Comparative Study
- Abstract Number: 2098
Distinctive Pattern of LTBI Screening Parameters in Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA) in Endemic Areas
- Abstract Number: 786
Distinguishing S100 Proteins and Cytokine Levels Between Active and Inactive Uveitis in Children with Juvenile Idiopathic Arthritis
- Abstract Number: 2536
Distribution and Predictors of Whole Blood Hydroxychloroquine Levels in Clinical Rheumatology Practices in the United States
- Abstract Number: 820
Diurnal Stability of Transcriptional Profiles in Rheumatoid Arthritis
- Abstract Number: 1985
Divergent Mononuclear Cell Participation and Cytokine Release Profiles Define Hip and Knee Osteoarthritis
- Abstract Number: 493
Diversity Analysis of Intestinal Flora in Patients with Rheumatoid Arthritis
- Abstract Number: 1465
Diversity Analysis of Intestinal Flora in Patients with Sjogren’s Syndrome
- Abstract Number: 2469
Diversity of Poly-Functional T Cells in Psoriatic Arthritis and Rheumatoid Arthritis and Its Therapeutic Significance
- Abstract Number: 2906
DMARD-free Remission in Established Rheumatoid Arthritis: 2 Year Results of the TARA Trial
- Abstract Number: 2395
DMARD-naïve Rheumatoid Arthritis (RA) Patients Have Greater RAPID3 Improvement over 6 Months After 1st Visit Than Patients Who Were Treated Previously Treated with DMARDs, Although Baseline RAPID3 Was Similar: The Importance of Early Treatment
- Abstract Number: 1030
DNA Methylation Changes Are Associated with Particulate Matter 2.5 Exposure in SLE Patients
- Abstract Number: 2396
DNA Methylation of the Dual Specificity Phosphatase 22 (DUSP22) Gene Promoter in Plasma and Medication Use in Rheumatoid Arthritis (RA)
- Abstract Number: 789
DNASE1L3 Variant in Hypocomplementemic Urticarial Vasculitis Syndrome Identifies a Different Clinical Phenotype
- Abstract Number: 1616
Do All Antiphospholipid Antibodies Confer the Same Risk for Major Organ Involvement in Systemic Lupus Erythematosus Patients?
- Abstract Number: 2554
Do All Patients Who Achieve Lupus Low Disease Activity State Have Similar Outcomes?
- Abstract Number: 604
Do Illness Perceptions and Coping Change over Time in Patients Recently Diagnosed with Axial Spondyloarthritis? A 2-Year Follow-Up Study in the SPACE Cohort
- Abstract Number: 2329
Do Myocardial Inflammation and Microvascular Dysfunction in RA Lead to Adverse Changes in Left Ventricular Structure and Function over Time? A Longitudinal Analysis of Participants from Rheumatoid Arthritis: Study of the Myocardium
- Abstract Number: 2836
Do Serum Urate-associated Genetic Variants Differentially Contribute to Gout Risk According to Body Mass Index? Analysis of the UK Biobank
- Abstract Number: 1230
Do Serum Urate-Associated Genetic Variants Influence Gout Risk in People on Diuretics? Analysis of the UK Biobank
- Abstract Number: 854
Do Smoking and Socio-economic Factors Independently Influence Imaging Outcomes in Axial Spondyloarthritis? Five-year Data from the DESIR Cohort
- Abstract Number: 311
Documenting Bone Health for Veterans with Rheumatoid Arthritis in an Outpatient Academic Clinic: A Multiphase Quality Improvement Project
- Abstract Number: 205
Does a Mandatory Non-medical Switch from Originator to Biosimilar Etanercept Lead to Increase in Healthcare Use and Costs? A Danish Register-based Study of 1620 Patients with Inflammatory Arthritis
- Abstract Number: 1846
Does Cartilage Loss Cause Pain in Osteoarthritis?
- Abstract Number: 2404
Does Combined Therapy Affects Adherence in Rheumatoid Arthritis?
- Abstract Number: 739
Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities?
- Abstract Number: 837
Does Discordance Between Baseline Patient’s and Evaluator’s Global Assessment of Disease Activity Impact Retention and Remission Rates of a First TNF Inhibitor in Patients with Axial Spondyloarthritis? Data from the EuroSpA Research Collaboration Network
- Abstract Number: 1088
Does Drug Effectiveness of 2nd and 3rd TNF Inhibitors in Patients with Psoriatic Arthritis Depend on the Reason for Withdrawal from the Previous Treatment? – Results from the EuroSpA Research Collaboration
- Abstract Number: 2799
Does Early Anterior Cruciate Ligament Reconstruction Prevent Further Meniscal Damage? Secondary Analysis of a Randomized Controlled Trial
- Abstract Number: 216
Does Fibromyalgia Change the Evaluation of Spondyloarthritis Activity? A Meta-analysis of Observational Studies
- Abstract Number: 432
Does Improvement in Patient Pain and Fatigue Lag Behind Clinical Remission in Rheumatoid Arthritis Patients? Data from a Rheumatoid Arthritis Registry
- Abstract Number: 2810
Does Loss-of-function Variants in SAT1 Cause X-linked Pediatric Lupus?
- Abstract Number: 1676
Does Pneumocystis Jiroveci Pneumonia (PJP) Prophylaxis Prevent Hospitalizations for Other Infections in Vasculitis Patients?
- Abstract Number: 1662
Does PR3-ANCA+ Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)Really Exist?
- Abstract Number: 1551
Does Retention and Remission Rates to 2nd and 3rd TNF Inhibitors in Patients with Axial Spondyloarthritis Depend on the Reason from Withdrawal to the Previous Treatment? – Real World Data from 12 European Countries in the EuroSpA Research Collaboration
- Abstract Number: 2924
Does the Degree of Decline in Walking Speed Predict Mortality Risk Beyond the Present Level of Walking Speed in Knee Osteoarthritis?
- Abstract Number: 289
Doppler in Entheses: A Potential Useful Outcome in Active Spondyloarthritis and Psoriatic Arthritis
- Abstract Number: 1153
Double Trouble: Utility of Serial TB Screening in a Rheumatology Clinic Serving a Foreign-Born Population
- Abstract Number: 1687
Dramatic but Suspensive Effect of interleukin-1 Inhibitors on Persistent Urticarial Vasculitis
- Abstract Number: 586
Drug Concentrations and Anti-drug Antibodies Influence in Response to Adalimumab: Results from the BioEfficacySpA Clinical Trial
- Abstract Number: 752
Drug Retention and Discontinuation Reasons Between Seven Biologics in Patients with Takayasu Arteritis
- Abstract Number: 2856
Drug Retention of Biological DMARDs Targeting IL-12/IL-23 or IL-17 versus TNF Inhibitors, After a First Line TNF Inhibitor, in Patients with Psoriatic Arthritis – an Analysis in the Swiss SCQM Register
- Abstract Number: 1555
Drug Survival and Safety of Biosimilar CT-P13 versus Reference Infliximab in Patients with Ankylosing Spondylitis: Data from the Korean College of Rheumatology Biologics Registry
- Abstract Number: 1548
Drug Survival of Secukinumab for Axial Spondyloarthritis in a Real-World Setting Possible Response Factors
- Abstract Number: 1511
Drug Survival of Ustekinumab in Psoriatic Arthritis: A Real-World Multicentric Cohort of 252 Patients
- Abstract Number: 1713
Drug-induced IgA Vasculitis: Data from the French Pharmacovigilance Network and the WHO VigiBase
- Abstract Number: 1458
Dual Analysis with Nerve Ultrasound and Skin Biopsy in Painful Neuropathy Associated with Sjögren’s Syndrome
- Abstract Number: 2205
Dual Femur Bone Density Measurements with Novel Sonographic Approach – Radiofrequency Echographic Multi Spectrometry
- Abstract Number: 937
Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Ankylosing Spondylitis: 48-Week Efficacy and Safety Results from a Phase 2b, Randomized, Blinded, Placebo-Controlled, Dose-Ranging Study
- Abstract Number: 2881
Dual Neutralization of IL-17A and IL-17F with Bimekizumab in Patients with Active Psoriatic Arthritis: Disease Activity and Remission in a 48-Week Phase 2b, Randomized, Double‑Blind, Placebo-Controlled, Dose-Ranging Study
- Abstract Number: 231
Duloxetine for Chronic Pain Management in a Tertiary Care Rheumatology Practice: How Patients Are Doing in the Real World
- Abstract Number: 1384
Duration of Oral Corticosteroid Therapy Does Not Change with the Addition of a Parenteral Injection: Results from a Real-World Canadian Early RA Cohort
- Abstract Number: 1025
Dynamic Changes During SLE Flare Implicate Age-Associated B Cells and Altered T Follicular and Peripheral Helper Cell Responses in Disease Activity
- Abstract Number: 754
Dynamic Distribution and Phenotype Shift from M1 to M2 of Macrophages in Vascular Lesions of Naïve and Treated Patients with Takayasu Arteritis
- Abstract Number: 83
Dysfunction of TRIM21 Promotes Aberrant Plasmablast Differentiation in Systemic Lupus Erythematosus Due to the Reduction of TRIM21-mediated Ubiquitylation of IRF5
- Abstract Number: 1066
Dysregulated IL-6 Dependent Dermal Adenosine Signaling via Adenosine A2A Receptor May Drive Fibrosis in Systemic Sclerosis
- Abstract Number: 2027
Dysregulation of Granulopoiesis in Systemic Lupus Erythematosus
2019 ACR/ARP Annual Meeting
November 8-13, 2019. Atlanta, GA.